By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A US federal court has dismissed Illumina lawsuits alleging Affymetrix infringes on patents covering array technologies.

In a decision handed down on Tuesday, Judge Barbara Crabb of the US District Court for the Western District of Wisconsin granted summary judgment for Santa Clara, Calif.-based Affymetrix, saying the company does not infringe on US Patent numbers 7,510,841 and 7,612,020 and dismissed the cases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.